Defining a High-Risk Subgroup of Pathological T2N0 Gastric Cancer by Prognostic Risk Stratification for Adjuvant Therapy
Authors:
- 1 December 2011
- journal article
- research article
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 15 (12) , 2153-2158
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Impact of lymphovascular invasion in patients with stage I gastric cancerSurgery, 2010
- Survival after radiotherapy in gastric cancer: Systematic review and meta-analysisRadiotherapy and Oncology, 2009
- Gastrosplenic Fistula From Hodgkin's LymphomaJournal of Clinical Oncology, 2009
- Adjuvant Chemotherapy for Gastric Cancer with S-1, an Oral FluoropyrimidineNew England Journal of Medicine, 2007
- Prevalence and prognosis of gastric cancer detected by screening in a large Japanese population: Data from a single institute over 30 yearsJournal of Gastroenterology and Hepatology, 2007
- Prognostic indicators of gastric carcinoma confined to the muscularis propriaHistopathology, 2007
- Development and Validation of a Risk Score for Predicting Death in Chagas' Heart DiseaseNew England Journal of Medicine, 2006
- An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomachInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2005
- Improving outcomes in gastric cancer over 20 yearsGastric Cancer, 2004
- Chemoradiotherapy after Surgery Compared with Surgery Alone for Adenocarcinoma of the Stomach or Gastroesophageal JunctionNew England Journal of Medicine, 2001